glp 1 medullary thyroid cancer GLP-1 medications and risk Glucagon-like peptide-1 medicines and cancer

The weight loss from these medications includes both fat and muscle, and older patients have less metabolic reserve to recover lost muscle mass

This problem is more common than most realize, affecting most women at some point in their lives

The DMPI is dedicated to understanding the molecular makeup of obesity and type 2 diabetes and the cardiovascular disease that often accompanies them, and to developing early-detection strategies and new treatments

That distinction matters because there is a major difference between losing fat while preserving strength and losing fat while simultaneously becoming physically weaker